pomalidomide has been researched along with dBET6 in 1 studies
| Studies (pomalidomide) | Trials (pomalidomide) | Recent Studies (post-2010) (pomalidomide) | Studies (dBET6) | Trials (dBET6) | Recent Studies (post-2010) (dBET6) |
|---|---|---|---|---|---|
| 623 | 121 | 552 | 8 | 0 | 8 |
| Protein | Taxonomy | pomalidomide (IC50) | dBET6 (IC50) |
|---|---|---|---|
| Transcription intermediary factor 1-alpha | Homo sapiens (human) | 1.96 | |
| Bromodomain-containing protein 4 | Homo sapiens (human) | 0.0654 | |
| E3 ubiquitin-protein ligase TRIM33 | Homo sapiens (human) | 4.69 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castellani, B; Cruciani, G; Desantis, J; Eleuteri, M; Goracci, L; Valeri, A | 1 |
1 other study(ies) available for pomalidomide and dBET6
| Article | Year |
|---|---|
Understanding the Metabolism of Proteolysis Targeting Chimeras (PROTACs): The Next Step toward Pharmaceutical Applications.
Topics: Aldehyde Oxidase; Antineoplastic Agents; Cells, Cultured; Cytochrome P-450 CYP3A; Drug Discovery; Drug Stability; Hepatocytes; Humans; Molecular Structure; Proteolysis; Small Molecule Libraries | 2020 |